Toxicity and carcinogenicity of Delta(9)-tetrahydrocannabinol in Fischer rats and B6C3F1 mice

被引:71
作者
Chan, PC [1 ]
Sills, RC [1 ]
Braun, AG [1 ]
Haseman, JK [1 ]
Bucher, JR [1 ]
机构
[1] TSI MASON RES INST,WORCESTER,MA 01608
来源
FUNDAMENTAL AND APPLIED TOXICOLOGY | 1996年 / 30卷 / 01期
关键词
D O I
10.1006/faat.1996.0048
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Delta(9)-Tetrahydrocannabinol (Delta(9)-THC) was studied for potential carcinogenicity in rodents because it is the principal psychoactive ingredient in marihuana and it has potential medicinal uses. Delta(9)-THC in corn oil was administered by gavage to groups of male and female Fischer rats and B6C3F1 mice at 0, 5, 15, 50, 150, or 500 mg/kg, 5 days a week for 13 weeks and for 13-week plus a 9-week recovery period, and to groups of rats at 0, 12.5, 25, or 50 mg/kg and mice at 0, 125, 250, or 500 mg/kg, 5 times a week for 2 years. In all studies, mean body weights of dosed male and female rats and mice were lower than controls but feed consumptions were similar. Convulsions and hyperactivity were observed in dosed rats and mice; the onset and frequency were dose related. Serum FSH and LH levels in all dosed male rats and corticosterone levels in 25 mg/kg female rats were significantly higher than controls at 15 months in the 2-year studies. Delta(9)-THC administration for 13 weeks induced testicular atrophy and uterine and ovarian hypoplasia; the lesions persisted in a 9-week recovery period. In the 2-year studies, survival of dosed rats was higher than controls; that of mice was similar to controls. Incidences of testicular interstitial cell, pancreas and pituitary gland adenomas in male rats, mammary gland fibroadenoma and uterus stromal polyp in female rats, and hepatocellular adenoma/carcinoma in male and female mice were reduced in a dose-related manner. Decreased tumor incidences may be at least in part due to reduced body weights of dosed animals. Incidences of thyroid gland follicular cell hyperplasia were increased in all dosed groups of male and female mice, and follicular cell adenomas were significantly increased in the 125 mg/kg group of males, but there was no evidence of a dose-related trend in proliferative lesions of the thyroid. There was no evidence that Delta(9)-THC was carcinogenic in rats or mice. (C) 1996 Society of Toxicology
引用
收藏
页码:109 / 117
页数:9
相关论文
共 26 条
[1]  
ABEL EL, 1984, NEUROBEH TOXICOL TER, V6, P29
[2]   EFFECTS OF SYNTHETIC DELIA - TETRAHYDROCANNABINOL ON PREGNANCY AND OFFSPRING IN RAT [J].
BORGEN, LA ;
PACE, HB ;
DAVIS, WM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1971, 20 (04) :480-&
[3]  
BORNHEIM LM, 1989, BIOCH PHYSL SUBSTANC, V1, P22
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]  
DEWEY WL, 1986, PHARMACOL REV, V38, P151
[6]   MULTIPLE COMPARISONS USING RANK SUMS [J].
DUNN, OJ .
TECHNOMETRICS, 1964, 6 (03) :241-&
[7]   CANNABINOIDS AND THE HIPPOCAMPAL GLUCOCORTICOID RECEPTOR - RECENT FINDINGS AND POSSIBLE SIGNIFICANCE [J].
ELDRIDGE, JC ;
MURPHY, LL ;
LANDFIELD, PW .
STEROIDS, 1991, 56 (05) :226-231
[8]  
GART JJ, 1979, J NATL CANCER I, V62, P957
[10]   NEOPLASMS OBSERVED IN UNTREATED AND CORN-OIL GAVAGE CONTROL-GROUPS OF F344/N RATS AND (C57BL/6N X C3H/HEN)F1 (B6C3F1) MICE [J].
HASEMAN, JK ;
HUFF, JE ;
RAO, GN ;
ARNOLD, JE ;
BOORMAN, GA ;
MCCONNELL, EE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1985, 75 (05) :975-984